Category: 2017 – 2
2017
PopularThe unique contribution of One Health to combating Antibiotic Resistance
Dr Steven L Solomon, Director, Global Public Health Consulting, Georgia, USA One Health is the concept that the optimum health for people, animals and the environment can best be ensured through the ongoing cooperative efforts...
Economics and Innovation
LatestThe Economics of reducing antibiotic use to reduce antimicrobial resistance
Dr Edward I Broughton Director of Research and Evaluation, Q&P Institute, USAID ASSIST URC, USA Human consumption of antibiotics is only beneficial to societal welfare when the correct antibiotics are used and they are given...
2017
Healthcare
PopularIntensive care units as epicentres for antimicrobial resistance development
Dr Jean Carlet President, World Alliance Against Antibiotic Resistance and Professor Jan De Waele, Intensivist, Ghent University Hospital, Belgium Antimicrobial resistance (AMR) is rapidly increasing to a dangerous level...
Economics and Innovation
Top RatedSocioeconomics, antimicrobial use and antimicrobial resistance
Molly Miller-Petrie Research Associate, CDDEP and Hellen Gelband, Associate Director for Policy, CDDEP Global patterns of health and disease vary by national economic status, and individual health and healthcare are also heavily...
All
Latest
Phage therapy: A promising weapon in the global superbug crisis
Phage therapy: A promising weapon in the global superbug crisis Dr Steffanie Strathdee, Associate Dean of Global Health Sciences, Harold Simon Professor of Medicine and Co-Director, Center for Innovative Phage Applications
- All
- Diagnostics
- Rational use of antibiotics
Phage therapy: A promising weapon in the global superbug crisis
Phage therapy: A promising weapon in the global superbug crisis Dr Steffanie Strathdee, Associate Dean of Global Health Sciences, Harold Simon Professor of Medicine and Co-Director, Center for Innovative Phage Applications
Augmented* medicine for all
Fabienne Ostermeyer, International Development Director, Visiomed Group International Imagine if...
The evolution of the global antibiotic resistance partnership
Hellen Gelband, Associate Director for Policy, Center for Disease Dynamics, Economics & Policy...
Global Health Dynamics
Cancer Control
